Stocktoria
Ultragenyx Pharmaceutical Inc. RARE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-01-31
Ultragenyx Pharmaceutical Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 5,603,352 | $230.3M |
| AQR CAPITAL MANAGEMENT LLC | 4,578,024 | $95.9M |
| CITADEL ADVISORS LLC | 2,371,391 | $49.7M |
| TWO SIGMA INVESTMENTS, LP | 2,205,820 | $46.2M |
| MILLENNIUM MANAGEMENT LLC | 1,772,184 | $37.1M |
| D. E. Shaw & Co., Inc. | 1,261,018 | $26.4M |
| Point72 Asset Management, L.P. | 893,295 | $18.7M |
| RENAISSANCE TECHNOLOGIES LLC | 561,700 | $11.8M |
Source: SEC EDGAR filings · CIK 0001515673 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.